Sexcord/ stromal ovarian tumors epidemiology and demographics

Jump to navigation Jump to search

Sexcord/ stromal ovarian tumors Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sexcord/ Stromal Ovarian Tumors from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sexcord/ stromal ovarian tumors epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sexcord/ stromal ovarian tumors epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sexcord/ stromal ovarian tumors epidemiology and demographics

CDC on Sexcord/ stromal ovarian tumors epidemiology and demographics

Sexcord/ stromal ovarian tumors epidemiology and demographics in the news

Blogs on Sexcord/ stromal ovarian tumors epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Sexcord/ stromal ovarian tumors epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Epidemiology and Demographics

Incidence

Ovarian sex cord-stromal tumors are very uncommon neoplasms that represent only 7% of all ovarian tumors[1][2]

  • The yearly adjusted incidence rate is approximately 2 per 1,000,000 women for SCSTs
Ovarian cancer incidence exhibits wide geographic variation,Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14(1):9–32. doi:10.20892/j.issn.2095-3941.2016.0084, http://creativecommons.org/licenses/by-nc-sa/4.0/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365187/

Prevalence

  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
  • The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

The age at presentation varies depending on the subtypes of sexcord-stromal ovarian tumors:[3]

Fibromas:

  • Although they can present at any age, the mean age of occurrence is in the late forties

Thecomas:

  • They are more likely to occur in postmenopausal women

Sclerosing stromal tumor(SSTs):

  • SSTs are more likely to occur in young women
  • Approximately 80% of the reported cases are under 30 years of age
  • A few cases have been reported in premenarchal girls, although SSTs most commonly occur after menarche

Steroid cell tumors:

  • The average age of presentation is 43 years

Adult and juvenile granulosa cell tumors:

  • The incidence of adult granulosa cell tumors peaks in early postmenopausal women
  • The juvenile form occurs predominantly in children and young women (<30 years)

Race

  • Racial predilection do exist for sexcord-stromal ovarian tumors[2]
  • Racial differences in incidence and mortality within the United States are similar to the observed international variation
  • Sexcord-stromal ovarian tumors(SCSTs) have more predilection in women of Caucasian background
  • Rates are highest among Whites, intermediate for Hispanics, and lowest among Blacks, and Asian people

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

Developing Countries

References

  1. Reid BM, Permuth JB, Sellers TA (February 2017). "Epidemiology of ovarian cancer: a review". Cancer Biol Med. 14 (1): 9–32. doi:10.20892/j.issn.2095-3941.2016.0084. PMC 5365187. PMID 28443200.
  2. 2.0 2.1 Boussios S, Zarkavelis G, Seraj E, Zerdes I, Tatsi K, Pentheroudakis G (October 2016). "Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies". Anticancer Res. 36 (10): 5031–5042. doi:10.21873/anticanres.11072. PMID 27798862.
  3. Horta M, Cunha TM (2015). "Sex cord-stromal tumors of the ovary: a comprehensive review and update for radiologists". Diagn Interv Radiol. 21 (4): 277–86. doi:10.5152/dir.2015.34414. PMC 4498422. PMID 26054417.

Template:WH Template:WS